Advertisement

Topics

Cingulate, Camargo Enter Regulatory Consulting Agreement

04:43 EDT 8 Aug 2017 | Contract Pharma

To provide regulatory consulting and strategic development services for two ADHD drugs

Original Article: Cingulate, Camargo Enter Regulatory Consulting Agreement

NEXT ARTICLE

More From BioPortfolio on "Cingulate, Camargo Enter Regulatory Consulting Agreement"

Quick Search
Advertisement
 

Relevant Topic

Attention deficit hyperactivity disorder (ADHD)
Attention deficit hyperactivity disorder (ADHD) is a group of behavioural symptoms that include inattentiveness, hyperactivity and impulsiveness. Attention deficit disorder (ADD) is a sub-type of ADHD - symptoms of ADHD include: a short attenti...